A 42-year-old woman with primary hyperparathyroidism is found to have elevated serum calcium and PTH levels. PTH acts via the cAMP second messenger system in osteoblasts and kidney. To confirm that the elevated PTH is producing appropriate downstream signaling effects through the cAMP pathway, which investigation would be most appropriate?

Explanation

## Assessing PTH-Mediated cAMP Signaling ### Why Urinary cAMP and Nephrogenous cAMP are Correct **Key Point:** Nephrogenous cAMP (cAMP excreted in urine in response to exogenous PTH infusion) is the gold-standard investigation to assess the functional integrity of the PTH receptor–cAMP signaling axis in the kidney. **High-Yield:** PTH binds to PTH1R (a G-protein coupled receptor) in the kidney and bone, activating Gs proteins and adenylyl cyclase. Measuring urinary cAMP after PTH stimulation directly reflects: - PTH receptor binding capacity - G-protein coupling - Adenylyl cyclase activity in renal tubular cells - End-organ responsiveness to PTH ### PTH Signaling Mechanism ```mermaid flowchart TD A[PTH binds PTH1R on renal tubule]:::action --> B[Gs protein activation]:::action B --> C[Adenylyl cyclase → cAMP]:::outcome C --> D[PKA activation]:::action D --> E[Phosphate reabsorption ↓]:::outcome D --> F[1α-hydroxylase activation]:::outcome F --> G[Calcitriol production ↑]:::outcome ``` **Mnemonic:** **CAMP** = **C**AMP **A**ssessment **M**easures **P**TH-receptor function ### Clinical Significance | Investigation | What It Measures | Clinical Use | |---|---|---| | Urinary cAMP (basal) | Baseline cAMP excretion | Baseline renal function | | Nephrogenous cAMP (post-PTH infusion) | Renal response to exogenous PTH | Confirms PTH receptor signaling integrity | | Serum 1,25-vitamin D | End-organ effect of PTH | Reflects overall PTH action, not pathway function | | Bone markers (ALP, P1NP) | Bone turnover | Reflects bone effects, not cAMP pathway | **Clinical Pearl:** In PTH-resistant states (e.g., pseudohypoparathyroidism type 1a), nephrogenous cAMP fails to rise appropriately despite high PTH levels, confirming a defect in the PTH receptor–cAMP axis rather than PTH deficiency. **Tip:** The question asks specifically about confirming that PTH is producing appropriate downstream cAMP signaling. Nephrogenous cAMP is the direct, functional measure of this pathway.